Long-term renal outcomes of patients with non-proliferative lupus nephritis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Although non-proliferative lupus nephritis (LN) (class I, II or V) has been considered as a less severe type of LN, data on long-term renal prognosis are limited. We investigated the long-term outcomes and prognostic factors in non-proliferative LN. Methods: We retrospectively reviewed patients with systemic lupus erythematosus who were diagnosed with LN class I, II, V, or II + V by kidney biopsy from 1997 to 2021. A poor renal outcome was defined as an estimated glomerular filtration rate (eGFR) of < 60 mL/min/1.73 m2. Results: We included 71 patients with non-proliferative LN (class I = 4; class II = 17; class V = 48; class II+V = 2), and the overall rate of poor renal outcomes was 29.6% (21/71). The univariate analysis indicated that older age, low eGFR at 6 or 12 months, failure to reach complete remission at 6 months, and LN chronicity score > 4 or activity score > 6 were significantly associated with poor renal outcomes. The multivariate analysis revealed that low eGFR at 6 months (HR 0.971, 95% CI 0.949–0.991; p = 0.014) was significantly associated with poor renal outcomes. Conclusions: Poor renal outcomes occurred in approximately 30% of patients with non-proliferative LN after long-term follow-up. More active management may be needed for non-proliferative LN, especially for patients with eGFR < 60 mL/ min/1.73 m2 at 6 months follow-up after LN diagnosis.
Abstract
Background/Aims: Although non-proliferative lupus nephritis (LN) (class I, II or V) has been considered as a less severe type of LN, data on long-term renal prognosis are limited. We investigated the long-term outcomes and prognostic factors in non-proliferative LN. Methods: We retrospectively reviewed patients with systemic lupus erythematosus who were diagnosed with LN class I, II, V, or II + V by kidney biopsy from 1997 to 2021. A poor renal outcome was defined as an estimated glomerular filtration rate (eGFR) of < 60 mL/min/1.73 m2. Results: We included 71 patients with non-proliferative LN (class I = 4; class II = 17; class V = 48; class II+V = 2), and the overall rate of poor renal outcomes was 29.6% (21/71). The univariate analysis indicated that older age, low eGFR at 6 or 12 months, failure to reach complete remission at 6 months, and LN chronicity score > 4 or activity score > 6 were significantly associated with poor renal outcomes. The multivariate analysis revealed that low eGFR at 6 months (HR 0.971, 95% CI 0.949–0.991; p = 0.014) was significantly associated with poor renal outcomes. Conclusions: Poor renal outcomes occurred in approximately 30% of patients with non-proliferative LN after long-term follow-up. More active management may be needed for non-proliferative LN, especially for patients with eGFR < 60 mL/ min/1.73 m2 at 6 months follow-up after LN diagnosis.
참고문헌 (31)
- Bernatsky S, "Mortality in systemic lupus erythematosus", Arthritis Rheum, 54, pp.2550~2557 (2006)
- Doria A, "Long-term prognosis and causes of death in systemic lupus erythematosus", Am J Med, 119, pp.700~706 (2006)
- Bomback AS, "Updates on the treatment of lupus nephritis", J Am Soc Nephrol, 21, pp.2028~2035 (2010)
- Bajema IM, "Revision of the International Society of Nephrology", Renal Pathology Society classification for lupus nephritis : clarification of definitions, and modified National Institutes of Health activity and chronicity indices, 2018, pp.93, 789~796
- Moroni G, "The long-term outcome of 93 patients with proliferative lupus nephritis", Nephrol Dial Transplant, 22, pp.2531~2539 (2007)
- Contreras G, "Sequential therapies for proliferative lupus nephritis", N Engl J Med, 350, pp.971~980 (2004)
- Chan TM, "Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group", N Engl J Med, 343, pp.1156~1162 (2000)
- Daleboudt GM, "The clinical relevance of a repeat biopsy in lupus nephritis flares", Nephrol Dial Transplant, 24, pp.3712~3717 (2009)
- Mok CC, "Treatment of pure membranous lupus nephropathy with prednisone and azathioprine : an open-label trial", Am J Kidney Dis, 43, pp.269~276 (2004)
- Austin HA, "Membranous lupus nephritis", Lupus, 14, pp.65~71 (2005)
- Chan TM, "Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression", Lupus, 8, pp.545~551 (1999)
- Beck LH Jr, "Treatment of membranous lupus nephritis : where are we now?", J Am Soc Nephrol, 20, pp.690~691 (2009)
- Hahn BH, "American College of Rheumatology. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis", Arthritis Care Res(Hoboken), 64, pp.797~808 (2012)
- Chen YE, "Value of a complete or partial remission in severe lupus nephritis", Clin J Am Soc Nephrol, 3, pp.46~53 (2008)
- Kidney Disease Outcomes Quality Initiative(K, "DOQI)", K, Am J Kidney Dis, pp.2004, 43(5 Suppl 1)[DOI]
- Weening JJ, "The classification of glomerulonephritis in systemic lupus erythematosus revisited", J Am Soc Nephrol, 15, pp.241~250 (2004)
- Ortega LM, "Review : lupus nephritis : pathologic features, epidemiology and a guide to therapeutic decisions", Lupus, 19, pp.557~574 (2010)
- MacKinnon M, "Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease : a systematic review of the efficacy and safety data", Am J Kidney Dis, 48, pp.8~20 (2006)
- Teplitsky V, "The renin-angiotensin system in lupus : physiology, genes and practice, in animals and humans", Lupus, 15, pp.319~325 (2006)
- Donadio JV Jr, "Prognostic determinants in lupus nephritis : a long-term clinicopathologic study", Lupus, 4, pp.109~115 (1995)
- Mok CC, "Lupus nephritis in Southern Chinese patients : clinicopathologic findings and long-term outcome", Am J Kidney Dis, 34, pp.315~323 (1999)
- Esdaile JM, "The time-dependence of long-term prediction in lupus nephritis", Arthritis Rheum, 37, pp.359~368 (1994)
- Tam LS, "Mesangial lupus nephritis in Chinese is associated with a high rate of transformation to higher grade nephritis", Lupus, 12, pp.665~671 (2003)
- Lentz RD, "Membranous transformation of lupus nephritis", Clin Immunol Immunopathol, 19, pp.131~138 (1981)
- Bomback AS, "Nonproliferative forms of lupus nephritis : an overview", Rheum Dis Clin North Am, 44, pp.561~569 (2018)
- Alsuwaida AO, "The clinical significance of serial kidney biopsies in lupus nephritis", Mod Rheumatol, 24, pp.453~456 (2014)
- Wang GB, "Changes in pathological pattern and treatment regimens based on repeat renal biopsy in lupus nephritis", Chin Med J(Engl), 125, pp.2890~2894 (2012)
- Ayodele OE, "Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis", Nephrology(Carlton), 15, pp.482~490 (2010)
- Austin HA 3rd, "Predicting renal outcomes in severe lupus nephritis : contributions of clinical and histologic data", Kidney Int, 45, pp.544~550 (1994)
- Zahab M, "Treatment outcomes of proliferative vs. non-proliferative adult lupus nephritis : a 10-year follow-up", Cureus, 13, pp.e16955~ (2021)
- Duran E, "Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis : single centre, cross-disciplinary experience", Lupus, 31, pp.1147~1156 (2022)